GRANULES INDIA (GRANULES.NS) Financials
GRANULES.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 52.6 billion | 23.0 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 49.0 billion | 20.7 billion |
GRANULES.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 1.0 billion | ? |
| 2023-09-30 | 1.1 billion | ? |
| 2023-06-30 | 984.8 million | ? |
| 2023-03-31 | 12.9 million | 12.9 million |
GRANULES.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.3 billion |
| 2023-09-30 | 1.0 billion |
| 2023-06-30 | 479.0 million |
| 2023-03-31 | 1.2 billion |
GRANULES.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 3.1 billion | 1.8 billion | 949.0 million |
| 2023-06-30 | 2.9 billion | - | - |
| 2023-03-31 | 3.2 billion | 2.2 billion | 776.1 million |
GRANULES.NS Shares Outstanding
GRANULES.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 1.8 billion | - | 1.5 billion | - |
| 2023-06-30 | - | - | 1.4 billion | - |
| 2023-03-31 | 4.1 billion | 369.8 million | 1.8 billion | 37.0 million |
GRANULES.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 11.6 billion | 5.0 billion |
| 2023-09-30 | 11.9 billion | 5.8 billion |
| 2023-06-30 | 9.9 billion | 4.8 billion |
| 2023-03-31 | 12.0 billion | 6.2 billion |
GRANULES.NS
Price: ₹401.95
Forward Dividend Yield: 0.37%
Payout Ratio: 9.20%
Dividend Per Share: 1.50 INR
Earnings Per Share: 16.31 INR
P/E Ratio: 25.88
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 96.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 19
DGR3: 17.78%
DGR5: 6.67%
DGR10: 26.90%